Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682238 · ClinicalTrials.gov registry record · Phase 2
A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis
A Phase 2 study, sponsored by Botanix Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT02682238 is a Phase 2 study that has completed, run by Botanix Pharmaceuticals. The registered enrollment target is 50 participants.
The verdict
NCT02682238, a Phase 2 study, has completed, sponsored by Botanix Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
To assess the safety and local tolerability of BBI-4000 15% gel compared with vehicle (placebo) when applied topically once daily in subjects with palmar hyperhidrosis.
Interventions
- OTHER Vehicle gel
- DRUG BBI-4000, 15%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-03-08 |
| Est. Completion | 2016-10-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682238
The ClinicalTrials.gov registry entry for NCT02682238 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Botanix Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle gel is the first listed.
NCT02682238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02682238 about?
NCT02682238 is a clinical study titled "A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis". To assess the safety and local tolerability of BBI-4000 15% gel compared with vehicle (placebo) when applied topically once daily in subjects with palmar hyperhidrosis.
What is the current status of trial NCT02682238?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2016-03-08. Estimated completion is 2016-10-04.
What interventions are being tested in trial NCT02682238?
The interventions under investigation include: Vehicle gel (OTHER), BBI-4000, 15% (DRUG).
Who is sponsoring clinical trial NCT02682238?
This trial is sponsored by Botanix Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.